Keywords: بیماری مننگوکوکی invasive; Neisseria meningitidis; Invasive meningococcal disease; Epidemiology; Meningococcal C conjugate vaccination; France;
مقالات ISI بیماری مننگوکوکی invasive (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بیماری مننگوکوکی invasive; Neisseria meningitidis; Pneumonia; Invasive meningococcal disease;
Keywords: بیماری مننگوکوکی invasive; anti-B PS IgM Ab; anti-serogroup B capsular polysaccharide IgM antibodies; BCA; bactericidal activity test; CFU; colony forming unit; ELISA; enzyme-linked immunosorbent assay; fH; factor H; fHbp; factor H-binding protein; GMT; geometric mean titre; IMD; i
Keywords: بیماری مننگوکوکی invasive; Meningococcal disease; Knowledge; Awareness; Survey; IMD; Invasive meningococcal disease; MenB; Meningococcal B; PBAC; Pharmaceutical Benefits Advisory Committee; SEIFA; Socio Economic Index for Areas;
Keywords: بیماری مننگوکوکی invasive; CI; confidence interval; GLM; generalised linear model; HDU; high dependence unit; ICU; intensive care unit; IMD; invasive meningococcal disease; IRR; incidence rate ratio; JCVI; Joint Committee on Vaccination and Immunisation; LOS; length of stay; MenB;
Keywords: بیماری مننگوکوکی invasive; AEFI; Adverse events following immunization; CCC; Complex chronic condition; CFR; Case fatality ratio; hSBA; Human serum bactericidal assay; ICER; Incremental cost-effectiveness ratio; IMD; Invasive meningococcal disease; IMPACT; Immunization Monitoring P
Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan
Keywords: بیماری مننگوکوکی invasive; Invasive meningococcal disease; Neisseria meningitidis; Sequence type 4821; Endemic strain; Serogroup C; Quinolone resistance;
Invasive Meningococcal Disease due to group C N. meningitidis ST11 (cc11): The Tuscany cluster 2015-2016
Keywords: بیماری مننگوکوکی invasive; Invasive Meningococcal Disease; Men C ST11 (cc11) cluster; Vaccination campaign;
Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy
Keywords: بیماری مننگوکوکی invasive; Invasive meningococcal disease; Meningococcal C conjugate vaccine; Vaccine effectiveness; Outbreak;
Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease
Keywords: بیماری مننگوکوکی invasive; Neisseria meningitidis; Invasive meningococcal disease; Whole genome typing;
Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized stu
Keywords: بیماری مننگوکوکی invasive; Quadrivalent meningococcal conjugate vaccine; Combined diphtheria-tetanus-acellular pertussis vaccine; Co-administration; Immunogenicity; Safety; AE; adverse event; ATP; according-to-protocol; CI; confidence interval; D; diphtheria; ELISA; enzyme-linked i
Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults
Keywords: بیماری مننگوکوکی invasive; ACIP; Advisory Committee on Immunization Practices; EMA; European Medicines Agency; FDA; US Food and Drug Administration; FHbp; factor H binding protein; GMT; geometric mean titer; HPV; human papillomavirus; hSBA; serum bactericidal assay using human comp
Antibody persistence and booster response 68â¯months after vaccination at 2-10â¯years of age with one dose of MenACWY-TT conjugate vaccine
Keywords: بیماری مننگوکوکی invasive; AEs; adverse events; ATP; according-to-protocol; CIs; confidence intervals; GI; gastrointestinal; GMTs; geometric mean titers; hSBA; serum bactericidal activity assay using human complement; IMD; invasive meningococcal disease; M; month; MenB; meningococc
Clonal replacement and expansion among invasive meningococcal isolates of serogroup W in France
Keywords: بیماری مننگوکوکی invasive; Neisseria meningitidis; Invasive meningococcal disease; Epidemiology; Serogroup W; Whole genome sequecning; France;
Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial
Keywords: بیماری مننگوکوکی invasive; Antibody persistence; Meningococcal B vaccine; Infants; Children; Booster response; 2Â +Â 1 schedule; Safety; Open-label randomised clinical trial; AE; adverse event; CI; confidence interval; FAS; full analysis set; fHbp; factor H-binding protein; GMT; ge
Clinical presentation and outcome of twenty cases of Invasive Meningococcal Disease due to Serogroup C - Clonal complex 11 in the Florence province, Italy, 2015-2016
Keywords: بیماری مننگوکوکی invasive; Neisseria meningitidis; Invasive Meningococcal Disease; Septic shock; Emergency Departments;
Durability of immunogenicity and strain coverage of MenBvac, a meningococcal vaccine based on outer membrane vesicles: Lessons of the Normandy campaign
Keywords: بیماری مننگوکوکی invasive; Neisseria meningitidis serogroup B; Serum bactericidal activity; Outbreak; Persistence of vaccine response; Invasive meningococcal disease; PorA; Vaccination;
Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination
Keywords: بیماری مننگوکوکی invasive; CI; confidence interval; GMC; geometric mean concentration; GMT; geometric mean titer; IMD; invasive meningococcal disease; MEC-U; Medical research Ethics Committees United; MenA; meningococcal serogroup A; MenC; meningococcal serogroup C; MenCC; meningoc
Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France
Keywords: بیماری مننگوکوکی invasive; Factor H binding protein; Invasive meningococcal disease; Neisseria meningitidis serogroup B; Outbreak; Bivalent rLP2086; MenB-FHbp;
Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil
Keywords: بیماری مننگوکوکی invasive; Neisseria meningitidis; Invasive meningococcal disease; Serogroup C meningococcal disease; Meningococcal vaccines; Vaccination impact; Surveillance; Data linkage; Interrupted time-series analysis;
A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults
Keywords: بیماری مننگوکوکی invasive; AE; adverse event; fHBP; factor H binding protein; HAV; hepatitis A virus vaccine; IMD; invasive meningococcal disease; MAE; medically-attended adverse event; MnB; Neisseria meningitidis serogroup B; NDCMC; newly-diagnosed chronic medical condition; SAE;
Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment
Keywords: بیماری مننگوکوکی invasive; IMD; invasive meningococcal disease; CFR; case fatality ratio; MCCV; meningococcal C conjugate vaccine; MCV4; quadrivalent meningococcal vaccine (serogroup A, C, Y and W); iPHIS; integrated Public Health Information System; PHOL; Public Health Ontario Lab
Evaluation of serogroup C and ACWY meningococcal vaccine programs: Projected impact on disease burden according to a stochastic two-strain dynamic model
Keywords: بیماری مننگوکوکی invasive; Dynamic model; Neisseria meningitidis; Meningococcal vaccines; Invasive meningococcal disease; Immunization programs; Stochastic model; Strain replacement;
Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination
Keywords: بیماری مننگوکوکی invasive; NCT01823536; Meningococcal vaccine; Childhood vaccination; Antibody persistence; Booster vaccination; hSBA; serum bactericidal assay using human complement; CRM197; non-toxic mutant of diphtheria toxin; IMD; invasive meningococcal disease; GMT; geometric
Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis
Keywords: بیماری مننگوکوکی invasive; Hajj clone; Invasive meningococcal disease; W135; Whole genome sequencing; Virulence factors; FHbp
Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adults
Keywords: بیماری مننگوکوکی invasive; IMD; invasive meningococcal disease; MenC; serogroup C meningococcal disease; MenB; serogroup B meningococcal disease; MCCV; meningococcal serogroup C conjugate vaccine; MenACWY; serogroups A, C, W, Y meningococcal disease; OMV; outer membrane vesicle; fH
Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae-N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy
Keywords: بیماری مننگوکوکی invasive; 95% CI; 95 percent confidence interval; ACIP; Advisory Committee on Immunization Practices; AE; adverse event; ATP; according-to-protocol; Coad; co-administration treatment group who received MenACWY-TTÂ +Â DTaP at the fourth dose visit (15/18 months of a
Immunogenicity and reactogenicity of Infanrix⢠when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix⢠and Pediarixâ¢
Keywords: بیماری مننگوکوکی invasive; 95% CI; 95 percent confidence interval; ACIP; Advisory Committee on Immunization Practices; AE; adverse event; ATP; according-to-protocol; Coad; co-administration treatment group who received MenACWY-TT+ DTaP at the fourth dose visit (15/18 months of age)
Zapobieganie zakażeniom meningokokowym - jak stosowaÄ obecnie dostÄpne szczepionki
Keywords: بیماری مننگوکوکی invasive; Neisseria meningitidis; inwazyjna choroba meningokokowa; szczepionki skoniugowane; Neisseria meningitidis; Invasive Meningococcal Disease; Conjugated vaccines;
Parental and community acceptance of the benefits and risks associated with meningococcal B vaccines
Keywords: بیماری مننگوکوکی invasive; ABS; Australian Bureau of Statistics; CD; collectors' districts; CI; confidence interval; EU; European Union; GP; general practitioner; IMD; invasive meningococcal disease; Men B; meningococcal serogroup B; Men ABCWY; meningococcal serogroup A, B, C, W,
Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)
Keywords: بیماری مننگوکوکی invasive; Serogroup B vaccines; 4CMenB coverage; Meningococcal Antigen Typing System; Invasive meningococcal disease; Meningitis;
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage
Keywords: بیماری مننگوکوکی invasive; CC; clonal complex; ELISA; enzyme-linked immunosorbent assay; fHBP; factor H binding protein; FN; false negatives; FP; false positives; HPA; Health Protection Agency; hSBA; serum bactericidal antibody assay with human complement; IMD; invasive meningococc
A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults
Keywords: بیماری مننگوکوکی invasive; (AEs); adverse events; (fHBP also known as rLP2086); factor H-binding protein; (GMT); geometric mean titre; (hSBA); human serum bactericidal assay; (IMD); invasive meningococcal disease; (Mn); meningococcal; (MnB); meningococcal serogroup B; (MnC); mening
Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine
Keywords: بیماری مننگوکوکی invasive; Invasive meningococcal disease; Surveillance; Meningococcal C vaccination; Germany; Strain characterization;
Keywords: بیماری مننگوکوکی invasive; Economic burden; Health care utilization; Invasive meningococcal disease
Added value of PCR-testing for confirmation of invasive meningococcal disease in England
Keywords: بیماری مننگوکوکی invasive; Invasive meningococcal disease; Meningococcal infections; Bacterial infections; Neisseria meningitidis; Polymerase chain reaction; Surveillance; Diagnosis
Considerations for controlling invasive meningococcal disease in high income countries
Keywords: بیماری مننگوکوکی invasive; Invasive meningococcal disease; Serogroup B; Vaccine safety; Outer membrane vesicle vaccines;
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy
Keywords: بیماری مننگوکوکی invasive; IBD; invasive bacterial disease; MCC; meningococcal serogroup C conjugate; Meningococcal meningitis; Invasive meningococcal disease; Vaccination strategies; Prevention; Efficacy; Tuscany (Italy);
Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccines
Keywords: بیماری مننگوکوکی invasive; Invasive meningococcal disease; Epidemiology; Infants; Adolescents; Vaccine; Capsular group B; Capsular group Y
Meningococcal disease: Clinical presentation and sequelae
Keywords: بیماری مننگوکوکی invasive; Neisseria meningitidis; Invasive meningococcal disease; Sequelae;
Consensus recommendation for meningococcal disease prevention in children and adolescents in the Middle East region
Keywords: بیماری مننگوکوکی invasive; Conjugate; Consensus recommendation; Invasive meningococcal disease; Middle East countries; Vaccine
Profilaktyka zakażeÅ meningokokowych - praktyczne aspekty szczepieÅ
Keywords: بیماری مننگوکوکی invasive; Neisseria meningitidis; inwazyjna choroba meningokokowa; szczepionki polisacharydowe; szczepionki skoniugowane; Neisseria meningitidis; Invasive meningococcal disease; Polysaccharide vaccines; Conjugate vaccines;
Secreted proteins of Neisseria meningitidis protect mice against infection
Keywords: بیماری مننگوکوکی invasive; Meningococcus; Meningitis; Invasive meningococcal disease; Host immune response; Vaccine; Bactericidal assay